Latham & Watkins and Wilson Sonsini Goodrich & Rosati advised Boundless Bio on the offering, and Cooley advised the underwriters. Boundless Bio, Inc. (Nasdaq: BOLD) a clinical...
Boundless Bio’s $100 Million IPO
Minsheng Vocational Education Company Limited v Leed Education Holding Limited & Ors
Wilson Sonsini Goodrich & Rosati collaborated with legal teams from Stephen Moverley Smith KC and Walkers with representing clients Leed Education Holding Limited, National Education Holding...
Aeovian Pharmaceuticals’ $50 Million Series A Financing Round
Wilson Sonsini Goodrich & Rosati advised Aeovian Pharmaceuticals on patent matters in connection with the transaction. Aeovian Pharmaceuticals, a clinical-stage biopharmaceutical company, announced it has raised...
Asari AI’s Funding Round
Wilson Sonsini Goodrich & Rosati represented Asari AI in the transaction. Asari AI announced that it has launched and raised an initial funding round led by...
Modal’s $25 Million Series A Financing Round
Wilson Sonsini Goodrich & Rosati advised Modal on the transaction. Modal, a leading skills development platform for data and analytics professionals, announced the completion of a...
Stoke Therapeutics’ $125 Million Upsized Common Stock Offering
Fenwick & West advised Stoke Therapeutics on the offering, Wilson Sonsini Goodrich & Rosati advised Stoke on IP matters and Davis Polk & Wardwell advised the...
RapidSOS’ $150 Million Financing Round
Wilson Sonsini Goodrich & Rosati advised RapidSOS on the transaction. RapidSOS announced it raised $75 million raise led by funds and accounts managed by BlackRock, which...
GDS International’s $587 Million Series A Investment
Wilson Sonsini Goodrich & Rosati represented Boyu Capital in connection with the transaction. GDS Holdings Limited (the “Company” or “GDSH”) (NASDAQ: GDS; HKEX: 9698), a leading...
UpLift’s Acquisition of TAO Connect
Wilson Sonsini Goodrich & Rosati represented UpLift in the transaction. UpLift, a technology-driven behavioral health company delivering in-network therapy and psychiatry, announced that it has acquired...
Genmab’s $1.8 Billion Acquisition of ProfoundBio
Cooley, Travers Thorp Alberga and Jun He Law Offices advised ProfoundBio and Wilson Sonsini Goodrich and Rosati advised ProfoundBio on patent matters related to the transaction,...
Orbillion’s $15 Million Funding Round
Wilson Sonsini Goodrich & Rosati represented Orbillion in the transaction. Cultivated meat start-up Orbillion announced it has raised fresh capital that brings its cumulative funding to $15...
ARCA Biopharma’s Merger with Oruka Therapeutics
Wilson Sonsini Goodrich & Rosati is advising ARCA biopharma, Inc. on the transaction, while Gibson, Dunn & Crutcher is advising Oruka Therapeutics and Cooley is advising...